Detalhe da pesquisa
1.
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.
Annu Rev Immunol
; 38: 673-703, 2020 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32340576
2.
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.
Cell
; 155(3): 531-9, 2013 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-24243013
3.
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.
Nature
; 596(7871): 268-272, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34107529
4.
Modeling resistance to the broadly neutralizing antibody PGT121 in people living with HIV-1.
PLoS Comput Biol
; 20(3): e1011518, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38551976
5.
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
N Engl J Med
; 384(19): 1824-1835, 2021 05 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33440088
6.
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
J Infect Dis
; 227(8): 939-950, 2023 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36348617
7.
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys.
Nature
; 540(7632): 284-287, 2016 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27841870
8.
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
Ann Intern Med
; 174(5): 585-594, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33587687
9.
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019.
Clin Infect Dis
; 73(11): e3996-e4004, 2021 12 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33031500
10.
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
JAMA
; 325(15): 1535-1544, 2021 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33704352
11.
Live-attenuated Chikungunya vaccine: a possible new era.
Lancet
; 401(10394): 2090-2091, 2023 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37321234
12.
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Lancet
; 392(10143): 232-243, 2018 07 21.
Artigo
Inglês
| MEDLINE | ID: mdl-30047376
13.
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.
Lancet
; 391(10120): 563-571, 2018 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29217375
14.
Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.
N Engl J Med
; 385(10): 951-953, 2021 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34260834
15.
Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys.
J Virol
; 92(15)2018 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29793950
16.
Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.
J Virol
; 92(13)2018 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29643249
17.
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.
Nature
; 503(7475): 224-8, 2013 Nov 14.
Artigo
Inglês
| MEDLINE | ID: mdl-24172905
18.
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
J Infect Dis
; 218(4): 633-644, 2018 07 13.
Artigo
Inglês
| MEDLINE | ID: mdl-29669026
19.
A global approach to HIV-1 vaccine development.
Immunol Rev
; 254(1): 295-304, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23772627
20.
Broadly Neutralizing Antibodies for HIV Eradication.
Curr HIV/AIDS Rep
; 13(1): 31-7, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26841901